ethyl 4-(1-methyl-5-nitrobenzimidazol-2-yl)butanoate

We are ethyl 4-(1-methyl-5-nitrobenzimidazol-2-yl)butanoate CAS:3543-72-4 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:  ethyl 4-(1-methyl-5-nitrobenzimidazol-2-yl)butanoate
CAS.NO:3543-72-4
Synonyms:
1-Methyl-5-nitro-1H-benzimidazole-2-butanoic acid ethyl ester

Molecular Formula:C14H17N3O4
Molecular Weight:291.30200

Physical and Chemical Properties:
Density: 1.3 g/cm3
Boiling point: 481ºC at 760 mmHg
Melting point: /
Flash point: 244.7ºC
Refractive index: 1.599

Specification:
Appearance:  White Crystalline Powder
Purity:≥99%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Refrigerator.Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Bendamustine hydrochloride CAS:3543-75-7
Intermediates of Bendamustine CAS:16506-27-7

Related News: Capacity: the bottleneck of business growth, expanding capacity and increasing utilization become a trend. Capacity is the core factor that determines the supply capacity of API companies. Insufficient capacity will cause companies to selectively complete orders and produce varieties, limiting the expansion of API products and market development.5-Amino-1,3,4-thiadiazole-2-thiol This is called API. A small amount of the active ingredient has an effect, so only a tiny part of the active ingredient is contained in medicine.TRANS-2-HEXENAL CAS:6728-26-3 In the context of the new medicine policy, with the development of China’s R & D strength, the number of innovative drugs approved has been blown out, which further strengthened the demand and speed of industrialization of raw materials in China.2,6-dibromonaftaleno CAS:13720-06-4 The API can be directly formulated, and the intermediate can only be used to synthesize the next product. Only through the intermediate can the API be manufactured.Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.